drugset / Trial / NCT02497040

The Effects of Scalp Block With Bupivacaine Versus Levobupivacaine

NCT02497040

Phase 4 Completed 90 enrolled Uludag University
RandomizedParallel-groupDouble-blindTreatment

Summary

Ninety American Society of Anesthesiologists (ASA) Physical Status classification system I-II patients were recruited for a randomised, placebo-controlled, double-blind study and were randomly divided into three groups to receive either 20 ml of 0.5% bupivacaine (Group B; n=30), 20 ml of 0.5% levobupivacaine (Group L; n=30) or saline as a placebo (Group C; n=30). Scalp block was performed 5 min before head pinning. The primary outcome of the study was mean arterial pressure (MAP) and secondary outcomes were heart rate (HR), visual analogue scale (VAS) scores, additional intraoperative and postoperative drug use. Postoperative pain was evaluated using a 10-cm visual analogue scale (VAS).

Timeline

Start
2008-03
Primary completion
2009-03
Completion
2009-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 0.5 % Other
Subject Bupivacaine Other / unclassified 20 ml Other
Subject Levobupivacaine Other / unclassified 0.5 % Other
Subject Levobupivacaine Other / unclassified 20 ml Other

Indications